safety tolerance metabolism broccoli sprout glucosinolates isothiocyanates clinical phase study pubmed ncbi abstract broccoli sprouts widely consumed parts world reported concerns respect tolerance safety humans formal phase study safety tolerance pharmacokinetics appeared justified sprouts vehicles delivery glucosinolate glucoraphanin cognate isothiocyanate sulforaphane num isothiocyanato num methylsulfinyl butane clinical trials trials designed evaluate protective efficacy development neoplastic diseases placebo-controlled double-blind randomized clinical study sprout extracts glucosinolates principally glucoraphanin precursor sulforaphane isothiocyanates principally sulforaphane conducted healthy volunteers in-patients clinical research unit subjects studied cohorts comprising treated individuals placebo recipient num day acclimatization period crucifer-free diet broccoli sprout extracts administered orally num intervals num days num doses subjects monitored period num days treatment doses num micromol glucosinolate cohort num micromol glucosinolate cohort num micromol isothiocyanate cohort cumulative excretion dithiocarbamates fraction dose similar cohorts num num num num dose higher consistent cohort num num dose thirty-two types hematology chemistry tests treatment period indicators liver transaminases thyroid thyroid-stimulating hormone total triiodothyronine num free thyroxine num function examined detail significant consistent subjective objective abnormal events toxicities sprout extract ingestions observed 
